Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Sales of Fujisawa's Funguard Well Ahead of Initial Forecast
December 29, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
December 29, 2003
- Sales of GE Pravastatin Having Difficulties: Elmed Eisai
December 29, 2003
- PRESS SEMINAR
December 29, 2003
- Kuraya Sanseido to Merge with ATOL, Everlth to Form MEDICEO
December 29, 2003
- DIAGNOSTIC NEWS IN BRIEF
December 29, 2003
- Wholesalers' Profits May Fall 30% This Fiscal Year: Mr Kimura of CR&C
December 29, 2003
- MEDICAL DEVICE NEWS IN BRIEF
December 29, 2003
- FPMAJ to Introduce Bar Code System Starting from Bio-derived Products
December 29, 2003
- WORLD NEWS IN BRIEF
December 29, 2003
- Quintiles' CSO Business Growing Rapidly
December 29, 2003
- The Value of New Medicines
December 29, 2003
- BUSINESS NEWS IN BRIEF
December 29, 2003
- MEETING
December 29, 2003
- Medical Fees Remain Unchanged
December 29, 2003
- Meet the Leaders (28)
December 29, 2003
- 5 Ingredients/9 Products Included in NHI List
December 29, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 29, 2003
- Proposed Basic Policy for FY2004 Medical Fee Revision Approved
December 29, 2003
- Semi-annual Business Results
December 22, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…